All articles by Ellen Daniel

  1. Takeda makes fourth offer of £44.3bn for Shire takeover

    Takeda Pharmaceutical Company has put forward a fourth offer to acquire Shire, a day after the Irish biopharmaceutical company best…
    Read More…

    24 Apr
  2. Fresenius backs out of Akorn buyout over data integrity requirements

    Fresenius has announced that it is terminating a merger agreement with generic pharmaceutical company Akorn due to Akorn’s ‘failure to…
    Read More…

    23 Apr
  3. DEA proposes rules to curb the manufacture of opioids

    The US Drug Enforcement Agency (DEA) has proposed stricter rules for the manufacture of prescription opioids by drug makers. The…
    Read More…

    23 Apr
  4. FDA committee supports first-ever approval of cannabis epilepsy drug

    The Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug Administration (FDA) has unanimously recommended…
    Read More…

    23 Apr
  5. PhRMA report reveals 537 neurological drugs currently in development

    A report by Pharmaceutical Research and Manufacturers of America (PhRMA) has found that over 500 medicines for neurological disorders are…
    Read More…

    23 Apr
  6. UK no longer ‘able to engage’ in EMA regulation post-Brexit

    The EMA has announced it has completed the reallocation of the medicines that the UK’s national regulator, the Medicines and…
    Read More…

    19 Apr
  7. Adocia to begin trial of blood sugar regulation technology

    French biotech Adocia has announced the initiation of a Phase I study of BioChaperone Pramlintide Insulin, a treatment that could…
    Read More…

    19 Apr
  8. Sempre Health and Novo Nordisk to partner to lower diabetes drug cost

    Sempre Health has announced that it is collaborating with Novo Nordisk on a pilot programme aimed at delivering cheaper diabetes…
    Read More…

    19 Apr
  9. Novo Nordisk and Red Cross to tackle NCDs in humanitarian crises

    Pharmaceutical company Novo Nordisk has announced it will work with The International Committee of the Red Cross (ICRC) and the…
    Read More…

    19 Apr
  10. AstraZeneca announces positive results for cancer drug trials

    AstraZeneca and MedImmune, its global biologics research and development arm, have presented positive trial data for two of its key…
    Read More…

    18 Apr